Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 4 studies | 17% ± 1% | |
epithelial cell | 4 studies | 34% ± 20% | |
plasma cell | 3 studies | 25% ± 5% | |
retinal cone cell | 3 studies | 20% ± 2% | |
GABAergic neuron | 3 studies | 35% ± 4% | |
glutamatergic neuron | 3 studies | 43% ± 6% | |
non-classical monocyte | 3 studies | 21% ± 5% | |
microglial cell | 3 studies | 21% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 28% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 774.22 | 1445 / 1445 | 100% | 5.69 | 183 / 183 |
ovary | 100% | 630.49 | 180 / 180 | 100% | 5.18 | 430 / 430 |
breast | 100% | 673.43 | 459 / 459 | 100% | 6.07 | 1116 / 1118 |
lung | 99% | 583.87 | 575 / 578 | 100% | 4.53 | 1155 / 1155 |
prostate | 100% | 663.67 | 245 / 245 | 99% | 4.05 | 498 / 502 |
brain | 99% | 488.09 | 2619 / 2642 | 100% | 3.83 | 704 / 705 |
pancreas | 100% | 477.69 | 328 / 328 | 99% | 3.63 | 176 / 178 |
thymus | 100% | 1039.61 | 653 / 653 | 99% | 5.41 | 598 / 605 |
uterus | 100% | 661.16 | 170 / 170 | 99% | 4.56 | 453 / 459 |
bladder | 100% | 688.81 | 21 / 21 | 98% | 3.70 | 494 / 504 |
intestine | 100% | 685.50 | 966 / 966 | 98% | 3.71 | 516 / 527 |
stomach | 100% | 546.28 | 359 / 359 | 98% | 3.79 | 280 / 286 |
kidney | 100% | 674.97 | 89 / 89 | 97% | 3.39 | 872 / 901 |
adrenal gland | 100% | 833.52 | 258 / 258 | 93% | 3.27 | 214 / 230 |
skin | 100% | 634.66 | 1809 / 1809 | 93% | 2.84 | 437 / 472 |
liver | 100% | 372.48 | 226 / 226 | 90% | 2.08 | 367 / 406 |
adipose | 100% | 584.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 4.09 | 29 / 29 |
muscle | 100% | 813.30 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 575.84 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 4.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.40 | 1 / 1 |
blood vessel | 100% | 768.67 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 626.51 | 825 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 71% | 349.58 | 658 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 69% | 1.66 | 55 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005525 | Molecular function | GTP binding |
GO_0016787 | Molecular function | hydrolase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNG1B |
Protein name | Zinc-regulated GTPase metalloprotein activator 1B (EC 3.6.5.-) (Cobalamin synthase W domain-containing protein 2) (COBW domain-containing protein 2) Zn regulated GTPase metalloprotein activator 1B |
Synonyms | CBWD2 |
Description | FUNCTION: Zinc chaperone that directly transfers zinc cofactor to target metalloproteins, thereby activating them. Catalyzes zinc insertion into the active site of methionine aminopeptidase METAP1, which function to cleave the initiator methionine from polypeptides during or after protein translation. Mechanistically, the N-terminal psi-PxLVp motif binds to the C6H2-type zinc finger of inactive form of METAP1. After formation of the docked complex, zinc is transferred from the CXCC motif in the GTPase domain of ZNG1B to the zinc binding site in the peptidase domain of METAP1 in a process requiring GTP hydrolysis. GTP/GDP exchange is required for release of active METAP1. . |
Accessions | Q8IUF1 C9J3G2 ENST00000358604.7 ENST00000456188.5 F8WFD0 ENST00000416503.6 ENST00000259199.9 F8WEU0 |